Treatment of lichen sclerosus with potassium para-aminobenzoate.
In five patients with symptomatic lichen sclerosus, significant clinical improvement was obtained following the administration of potassium para-aminobenzoate. Improvement was characterized by a marked decrease or absence of symptoms and a flattening of skin lesions.
D000328:Adult; D000368:Aged; D001565:Benzoates / Q000627:therapeutic use*; D019817:Benzoic Acid; D005260:Female; D006801:Humans; D007868:Leg Dermatoses / Q000188:drug therapy; D008875:Middle Aged; D011538:Pruritus Ani / Q000188:drug therapy; D011539:Pruritus Vulvae / Q000188:drug therapy; D012871:Skin Diseases / Q000188:drug therapy*
D001565:Benzoates; D019817:Benzoic Acid